Novel Pain Management Medications Under Development
Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients.
of Americans are affected by back pain at some point in their lives*
Estimated Epidural Steroid Injections (ESIs) procedures annually. ESIs are one of the most common medical procedures in the U.S.**
In the United States, Semnur Pharmaceuticals plans to develop and commercialize product candidates, either through its own efforts or in conjunction with partners. Outside of the United States, we anticipate commercializing these products through select regional partnerships worldwide.
Our primary focus lies in the development of non-opioid products for meeting the needs of underserved patients with back pain. We believe that the therapeutic advantages of our product and technology will improve products’ efficacy and safety making a substantial improvement in the treatment of back pain.
* NIH, National Institute of Arthritis and Musculoskeletal and skin diseases (n.d.). Back Pain: MedlinePlus.
** CDC, HCUP, Semnur data on file.